Enhanced Topical Delivery of a Small Molecule Receptor Tyrosine Kinase Inhibitor (RTKi) via Mucosal-Penetrating Particle Technology
Year: 2013
Type: article
Institution: Kala Pharmaceuticals (United States)
Language: English
Subfield: Pharmaceutical Science
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W771481671
